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Shihab U. Sobuz,c Rashidul Haque,c Kaisar A. Talukder,c Shahida Qureshi,d Anita Zaidi,d Doris M. Haverstick,e and Eric R. Houpta
Division of Infectious Diseases and International Health, Department of Medicine,a and Department of Pathology,e University of Virginia, Charlottesville, Virginia, USA;
Kilimanjaro Christian Medical Centre, Moshi, Tanzaniab; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladeshc; and Aga Khan University,
Karachi, Pakistand
Diarrhea can be caused by a range of pathogens, including several bacteria. Conventional diagnostic methods, such as culture,
biochemical tests, and enzyme-linked immunosorbent assay (ELISA), are laborious. We developed a 7-plex PCR-Luminex assay
to simultaneously screen for several of the major diarrhea-causing bacteria directly in fecal specimens, including pathogenic
Aeromonas, Campylobacter jejuni, Campylobacter coli, Salmonella, Shigella, enteroinvasive Escherichia coli (EIEC), Vibrio, and
Yersinia. We included an extrinsic control to verify extraction and amplification. The assay was first validated with reference
strains or isolates and exhibited a limit of detection of 103 to 105 CFU/g of stool for each pathogen as well as quantitative detec-
tion up to 109 CFU/g. A total of 205 clinical fecal specimens from individuals with diarrhea, previously cultured for enteric
pathogens and tested for Campylobacter by ELISA, were evaluated. Using these predicate methods as standards, sensitivities and
specificities of the PCR-Luminex assay were 89% and 94% for Aeromonas, 89% and 93% for Campylobacter, 96% and 95% for
Salmonella, 94% and 94% for Shigella, 92% and 97% for Vibrio, and 100% and 100% for Yersinia, respectively. All discrepant
results were further examined by singleplex real-time PCR assays targeting different gene regions, which revealed 89% (55/62
results) concordance with the PCR-Luminex assay. The fluorescent signals obtained with this approach exhibited a statistically
significant correlation with the cycle threshold (CT) values from the cognate real-time PCR assays (P< 0.05). This multiplex
PCR-Luminex assay enables sensitive, specific, and quantitative detection of the major bacterial causes of gastroenteritis.
Diarrheal disease is a leading cause of morbidity and mortalityworldwide, particularly in children. It can be caused by a host
of organisms, including viruses, parasites, fungi, and bacteria.
Some of the major bacterial pathogens observed in communities
throughout the world include Aeromonas, Campylobacter, diar-
rheagenic Escherichia coli, Salmonella, Shigella, Vibrio, and Yer-
sinia. In the United States, many such pathogens are reportable,
and these data indicate that Salmonella and Campylobacter jejuni/
Campylobacter coli aremost frequent, followed by Shigella species,
Shiga toxin-producing E. coli, Yersinia, Listeria, and Vibrio (9).
The microbiologic etiology of diarrhea is usually not clinically
obvious; thus, laboratory diagnosis is important, since many of
the bacteriamentioned, such as Shigella,Vibrio, andYersinia, usu-
ally warrant specific antibiotic therapy (18). Conventional culture
methods remain the norm for detection and identification of bac-
terial enteric pathogens in clinical laboratories, although studies
have repeatedly noted poor yield and high cost (11, 18, 24, 31, 50).
Moreover, culture detection and identification methods require
significant skill, labor, and time, which can delay epidemiological
investigation or treatment. Another complication is that many
bacteria are inherently difficult to grow (1, 44), are greatly affected
by prior antibiotics, and even may attain a so-called viable but
nonculturable state (35), a phenomenon that has been described
with Vibrio cholerae (12, 46), Vibrio vulnificus (45), Salmonella
enterica serovar Enteritidis (40), Shigella (12, 38), and Campylo-
bacter jejuni (8, 39). It is not surprising, therefore, that detection of
bacterial enteropathogens by stool culture has been insensitive
compared with that of enzyme-linked immunosorbent assay
(ELISA) and PCR-based methods (5, 14, 17, 27).
Molecular diagnostic assays on fecal specimens have recently
emerged for enteric pathogens, including several multiplex PCR
approaches using real-time cyclers (13, 14, 19), gel electrophoresis
(10, 16), or hybridization-based detection (34). Recently a rapid
4-plex real-time PCR assay detected Campylobacter, Salmonella,
Yersinia, and Shigella, with results comparable to those of culture
(13). There is also an EntericBio system (Serosep Ltd., Annacotty,
Ireland) that amplifies and detects Campylobacter, Shigella, Sal-
monella, and E. coliO157 from overnight enrichment broths with
line blot hybridization (34). We have performed PCR amplifica-
tion followed by detection on Luminex beads for several enteric
pathogens, including viruses and parasites (29, 41). This system
offers expandability given that current platforms can detect 100 or
more amplicon populations. Here, we present the same scheme to
detect Aeromonas, Campylobacter jejuni/Campylobacter coli, Sal-
monella, Shigella, enteroinvasive E. coli (EIEC), Vibrio, and Yer-
sinia. This panel can be added to other panels or used alone as a
screen for these pathogens.
MATERIALS AND METHODS
Specimens. Two hundred and five clinical fecal specimens were obtained
from patients from Kilimanjaro Christian Medical Centre, Tanzania, In-
ternational Centre for Diarrheal Diseases and Research, Bangladesh
Received 10 August 2011 Returned for modification 1 September 2011
Accepted 27 October 2011
Published ahead of print 9 November 2011
Address correspondence to Jie Liu, jl5yj@virginia.edu.
Supplemental material for this article may be found at http://jcm.asm.org/.
Copyright © 2012, American Society for Microbiology. All Rights Reserved.
doi:10.1128/JCM.05416-11
98 jcm.asm.org 0095-1137/12/$12.00 Journal of Clinical Microbiology p. 98–103
 o
n
 M
arch 27, 2018 by AG
A KHAN UNIV
http://jcm.asm.org/
D
ow
nloaded from
 
(ICDDRB), and Aga Khan University Hospital, Pakistan. All work was
approved by the respective andUniversity of Virginia (UVA) institutional
review boards. Samples were tested for Campylobacter using ELISA
(ProSpecT Campylobacter microplate; Remel, Lenexa, KS) by following
the manufacturer’s protocol and for other bacterial pathogens using cul-
ture as described below. There were 24 specimens from these sites that
were negative by all methods and were included in our evaluation of
clinical samples. DNAwas extracted with the QIAampDNA stool minikit
(Qiagen, Valencia, CA) by following the manufacturer’s protocol. For
spiking experiments, we utilized healthy volunteer stools from UVA and
extracted with QuickGene DNA Tissue Kit S (Fujifilm, Tokyo, Japan)
(41). Reference strains were obtained from the American Type Culture
Collection (Manassas, VA), and extra Salmonella strains were from the
SalmonellaGenetic Stock Centre (University of Calgary, Alberta, Canada)
(6). An exogenous phocine herpesvirus (PhHV-1), a gift from Martin
Schutten, Erasmus MC, Department of Virology, Rotterdam, The Neth-
erlands, was spiked into the lysis buffer for stool DNA extraction to mon-
itor the efficiency/inhibition of extraction and amplification. The viral
extract, estimated to be at a concentration of about 109 copies of genome
permilliliter, was titrated to yield optimal signal, with 2,000 copies spiked
into each fecal sample.
Conventional stool culture and biochemical test procedures. Two
hundred milligrams of fecal specimen was preserved in Cary-Blair trans-
port medium before culture. All culture media and reagents were ob-
tained from BD Biosciences (Franklin Lakes, NJ). MacConkey agar was
used to identify non-lactose-fermenting colonies for further testing. Xy-
lose lysine deoxycholate (XLD) agar and thiosulfate citrate bile sucrose
agar (TCBS) identified suspected Salmonella and Vibrio species, respec-
tively. Blood agar was used to distinguishAeromonas colonies fromVibrio
colonies. Suspicious colonies were selected for further identification using
biochemical methods and confirmed with serotyping as appropriate.
Design of a 7-plex PCR-Luminex assay.We aimed to simultaneously
detect the pathogenic strains of the six diarrhea-causing bacteria:Aeromo-
nas, Campylobacter, Salmonella, Shigella, Vibrio, and Yersinia. We chose
gene targets and evaluated an inclusivity panel of 129 strains as indicated
in Table S2 in the supplemental material. Targeted genes included aeroly-
sin for Aeromonas species, including A. hydrophila, A. caviae, and A. vero-
nii (23, 37, 49) (see Table S1 in the supplemental material). An assay
targeting invA, a gene widely used to detect Salmonella species (21, 30),
was designed. The ipaH assay detected all four Shigella species, S. boydii, S.
dysenteriae, S. flexneri, and S. sonnei, as well as EIEC without any differ-
entiation (43). A conserved region in the toxR gene was used for both
Vibrio cholerae and Vibrio parahaemolyticus. Assays targeting cadF and
lysP were adapted from the literature for Campylobacter (C. jejuni and C.
coli) and pathogenic Yersinia species, respectively (13).
Multiplex PCR. Primers (see Table S1 in the supplemental material)
were sourced from the published literature where possible, but with some
modifications (13, 33, 41, 43). Forward primers were labeled with biotin-
TEG (tetraethyleneglycol, 15 atoms) at 5= ends. Primer concentration was
titrated for optimal sensitivity according to the methods of Gunson et al.
(20), and then 7-plex primer mix was prepared to have final concentra-
tions of 3.1, 1.6, 12.5, 6.3, 12.5, 6.3, 12.5, 3.1, 12.5, 6.3, 3.1, 12.5, 1.6, 3.1,
and 3.1 M for forward and reverse primers of aerolysin-, cadF-, invA-,
ipaH-, toxR (two reverse primers)-, lysP-, and gB-targeting regions, re-
spectively. A 25-l multiplex reaction mixture typically contained 1
QiagenMultiplex PCRMasterMix, 2l of Q-solution, ll of primermix,
and 2 l of DNA sample. PCR was performed in a MyCycler thermal
cycler (Bio-Rad, Hercules, CA) under the following conditions: initial
denaturation at 95°C for 15 min; 40 cycles of 94°C for 30 s, 60°C for 30 s,
and 72°C for 1min; and a final 10-min extension at 72°C. Positive samples
and a negative control (nuclease-free water) were included on each 96-
well plate.
Microsphere-based Luminex detection. Oligonucleotide capture
probes (see Table S1 in the supplemental material) weremodified with an
amino-C12 linker at the 5= ends to enable coupling to the carboxylated
fluorescent microspheres (Bio-Rad). Bead coupling and hybridization
were performed according to published protocols (4, 28). Samples were
analyzed on the BioPlex 200 system (Bio-Rad). One hundred micro-
spheres of each set were analyzed, and the results were reported as
microsphere-specific median fluorescent intensity (MFI). Amplification
reactions for positive and negative controls were included in the assay.
Corrected MFI (cMFI) was calculated as follows: cMFI  (MFIanalyte 
MFInegative control)/MFInegative control. All positive-control cMFIs were
greater than 10.
Singleplex real-time PCR. The same designs (see Table S1 in the sup-
plemental material) were used for real-time PCR assays, except that
forward primers were not biotinylated and the capture oligonucleotides
were converted into 6-carboxyfluorescein (FAM)-labeled TaqMan-
MGB (minor groove binder) probes (Life Technologies, Carlsbad, CA).
Singleplex quantitative PCR (qPCR) was carried out with a CFX96 real-
time system (Bio-Rad) in a 20-l reaction mixture containing 10 l of
Quantitect PCR Master Mix (Qiagen), 10 pmol of each forward and re-
verse primer, 4 pmol of TaqMan probe, and 2 l of nucleic acid sample
under the following conditions: initial denaturation at 95°C for 15 min
and 40 cycles of 95°C for 15 s and 60°C for 1 min. The secondary assays
targeting different genes (see Table S1 in the supplemental material) were
run in a 20-l reaction mixture containing 10 l of SYBR IQ supermix
(Bio-Rad), 4 pmol of each forward and reverse primer, and 2l of nucleic
acid under the following conditions: initial denaturation at 95°C for 3min
and 40 cycles of 95°C for 15 s and 60°C for 1 min, followed by melting-
curve analysis which revealed single amplicons of an appropriate melting
temperature.
Performance on analytical specimens.Bacteria were grown in tryptic
soy broth, except for Vibrio, which was grown in nutrient broth with 3%
NaCl. Overnight cultures were serially diluted with phosphate-buffered
saline (PBS), plated onto blood agar plates, and incubated overnight to
determine the number of CFU. The same dilutions were spiked into
healthy donor fecal samples, extracted, and then amplified and detected
with the 7-plex PCR-Luminex assay. Genomic DNA was purified from
bacterial culture, and serial dilutions were prepared to evaluate linearity.
Statistics. Receiver operating characteristic (ROC) analysis per-
formed with PASW Statistics software was used to define cMFI cutoffs
using culture/ELISA results as the gold standard. Correlation among bac-
terial copy numbers, qPCRCT values, and cMFI fromPCR-Luminex assay
were tested by regression analysis using the analysis of variance (ANOVA)
test. All P values were two-tailed, and values 0.05 were considered sta-
tistically significant.
RESULTS
Performance on analytical specimens.The assay was validated as
follows (7). As shown in Table S2 in the supplemental material,
the assay was tested and positive on diverse reference strains or
clinical isolates for Aeromonas (n  7), Campylobacter (n  4),
Salmonella (n 95), Shigella (n 11),Vibrio (n 8), andYersinia
(n 3). An exclusivity panel of 25 pathogenic and nonpathogenic
organisms that can be present in feces was also tested and negative
(see Table S2 in the supplemental material). Reference strains of
Aeromonas hydrophila, Campylobacter jejuni, C. coli, Salmonella
enterica serovar Enteritidis, Shigella sonnei, Vibrio cholerae, V.
parahaemolyticus, and Yersinia enterocolitica were cultured, and
genomic DNA was extracted and quantified. Ten to 107 genomic
copies were amplified and detected with the 7-plex PCR-Luminex
assay, and linearity for each analyte was assessed as shown in Fig. 1
(V. cholerae), Fig. S1 in the supplemental material (the other bac-
teria), and Table 1 (summary). As we observed with our previous
PCR-Luminex assays (29), the cMFI statistically correlated with
copy numbers, but second-order polynomial regression was
tighter than linear fit (R2 0.85 to 0.96), andR2 values were not as
high as qPCR values using the same primers and probes (R2 
PCR-Luminex Assay for Enteric Bacteria
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0.995 to 1.000; P 0.001). The limit of detection was determined
by spiking healthy volunteer pathogen-negative stool and was
found to be 103 to 105 CFU/g depending on the pathogen (Table
1). Precision was examined with 10 fecal samples spiked with 105
CFU of bacterial culture, and the coefficient of variation (CV)
ranged from 4.7% to 11.9% within runs and from 6.0% to 19.7%
between runs over 5 days.
Validation with clinical samples. Two hundred and five clin-
ical diarrheal sampleswere obtained fromTanzania, Pakistan, and
Bangladesh, and 181 of them were previously tested positive for
bacterial pathogens via ELISA for Campylobacter and via culture
for the rest. ROC analysis was performed to ascribe the cMFI
cutoffs that would maximize sensitivity/specificity against the
conventional methods. This yielded an overall sensitivity and
specificity for the PCR-Luminex assay of 91.4% and 95.6%, re-
spectively (Table 2). Most of the discrepancies (46/62) were
Luminex-positive/conventional-method-negative results. Gener-
ally, the Luminex-positive/conventional-method-negative results
had lower fluorescence intensities than the Luminex-positive/
conventional-method-positive counterparts, although this was
only statistically significant for Salmonella (21.0  15.7 versus
5.5  2.4; P  0.01). qPCRs using the same designs were per-
formed on all 205 specimens, and results were 100% concordant
with the PCR-Luminex results (data not shown). Additionally,
secondary qPCR targeting a different gene for each analyte (see
Table S1 in the supplemental material) was performed to evaluate
the 62 discrepant results. These secondary qPCR results supported
the Luminex results in 89% (55/62) of instances (Table 3). If we
used 2 out of 3 concordant results as a gold standard for positivity
or negativity, the PCR-Luminex result offered 93 to 100% sensi-
tivity and 98 to 100% specificity across targets. The number of
positive Yersinia specimens was small; thus, our sensitivity confi-
dence interval was broad.
Mixed infections. With the conventional methods, only four
samples were found to be positive for multiple pathogens: two for
Campylobacter andVibrio, one forCampylobacter and Salmonella,
and one for Campylobacter and Aeromonas. In contrast, the PCR-
Luminex assay detected these 4 mixed infections plus an addi-
tional 23. The most common pathogens observed in mixed
infections were, in descending order,Campylobacter, Shigella, Sal-
monella, Vibrio, and Aeromonas.
Quantitation with the 7-plex PCR-Luminex assay. These
mixed infections raised the need for quantitation of enteropatho-
gens; thus, we explored this topic in detail. We already noted in
Fig. 1 and Fig. S1 in the supplemental material that in analytical
specimens the template copy numbers correlated quantitatively
with the PCR-Luminex fluorescence. We also noted in Fig. 2 that
the CT obtained by real-time PCR using the same designs statisti-
cally correlated with the PCR-Luminex result (P  0.0005 for
Aeromonas, Campylobacter, Salmonella, Shigella, and Vibrio).
These observations, however, do not account for stool-sample-to-
stool-sample variability in DNA extraction or PCR amplification.
Therefore, an extrinsic control, phocine herpesvirus (PhHV), was
spiked into each sample during extraction to ensure extraction/
amplification and normalization for quantitation (31). Sixteen
different stool specimens were each spiked with 2,000 copies of
PhHV and 103 to 108 CFU of Salmonella enterica serovar Enterit-
idis and examined for Salmonella cMFI or Salmonella/PhHVcMFI
ratio (see Fig. S2 in the supplemental material). The ratio yielded
a tighter correlation with spiked CFU than Salmonella cMFI alone
FIG 1 Correlation between template copy numbers and detection by multi-
plex PCR-Luminex assay (cMFI) for Vibrio cholerae. Best-fit lines and regres-
sion (R2) were extrapolated. The other bacteria are presented in Fig. S1 in the
supplemental material.
TABLE 1 Performance characteristics of the PCR-Luminex assay to detect bacterial enteropathogens
Pathogen Strain
Second-order polynomial
regression
Limit of detectiona
(CFU/g stool)
Precisionb (% CV)
Reportable range
(copies/PCR) R2 Within run Between runs
Aeromonas hydrophila Clinical isolate 102–107 0.98 104 11.12 15.82
Campylobacter jejuni ATCC 33291 102–107 0.96 103 9.58 16.27
Campylobacter coli ATCC 43473 103–107 0.91 105 11.10 18.63
Salmonella Enteritidis SARB no. 16 102–107 0.95 103 7.02 12.09
Shigella sonnei Clinical isolate 102–107 0.92 103 10.51 15.30
Vibrio cholerae Clinical isolate 102–107 0.97 104 6.20 14.78
Vibrio parahaemolyticus ATCC 17802 103–107 0.89 105 11.77 19.73
Yersinia enterocolitica ATCC 23715 102–107 0.98 104 4.72 6.07
a Limit of detection was determined with control fecal samples spiked with the lowest amount of bacterial culture that could be detected in 10/10 samples.
b Within-run precision and between-run (over 5 days) precision were both tested on 10 samples.
Liu et al.
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(R2 0.92 versus 0.71). Thus, the target/control ratio can be used
to accurately extrapolate bacterial burden. Another concern with
mixed infections is that one target may preferentially amplify over
another target.We evaluated this by cospiking 107 copies of targets
into the same PCR across 15 combinations and comparing ampli-
fication with 107 copies of a single target alone (see Table S3 in the
supplemental material). The combinations revealed that Aeromo-
nas, Salmonella, Shigella, and Yersinia were amplified efficiently
regardless of the presence of any of the other targets (P values of
0.05 between cMFIs of one target and two targets). In contrast,
Campylobacter detection remained but was diminished in the
presence of Salmonella orVibrio. These spiked amounts represent
high burden templates, and no loss of signal was detected when
only 104 copies of Salmonella orVibriowere cospiked (119.5 5.8
for Campylobacter alone versus 104.9 18.5 and 109.1 13.2 in
the presence of 104 copies of Salmonella and Vibrio, respectively;
P 0.05).
DISCUSSION
The value of this diagnostic assay is a molecular screen for several
common bacterial enteropathogens that can be used directly on
stool specimens. The assay has been validated for linearity, limit of
detection, precision, as well as sensitivity and specificity compared
to those of conventional culture/ELISA methods. It was tested
against clinical samples from around the world, including Paki-
stan, Tanzania, and Bangladesh. We propose its use for epidemi-
ologic studies. For example, in the context of recent severe gastro-
intestinal outbreaks of V. cholerae in Haiti, such an assay could be
useful as an early positive/negative indicator that drives the
workup forward. The assay provides quantitative information for
these pathogens, whichwe postulatemay be useful in the setting of
mixed infections and potentially to evaluate severity. It may also
find use in clinical settings. The assay is modular, such that addi-
tional panels could be added to include viruses, diarrheagenic E.
coli, or protozoa. Likewise, if some species are rare, as is often the
case with Vibrio and Yersinia, these reagents can be withheld.
Previous PCR-based assays to detect a broad range of enteric
bacteria have generally used several PCRs. Some havemultiplexed
the reactions, but usually to only four targets (2, 3). We were able
to achieve a 7-plex assay with a sensitivity of 89 to 100% and
specificity of 93 to 100% for all targets. Most discrepancies were
due to additional PCR-Luminex detections, which we generally
interpret as being true positives, where the PCR-Luminex assay
was more robust and sensitive. Indeed the analytical sensitivity of
our assay (103 to 105 CFU/g of stool) was below the bacterial
burden (103 to 109 CFU/g) often reported in symptomatic
patients as measured by culture (17, 26, 32). Furthermore, a sec-
ondary PCR targeting a different gene region yielded the PCR-
Luminex result in 93.5% of the Luminex-positive/conventional-
method-negative samples. There were also small numbers of
PCR-negative/conventional-method-positive results, which could
reflect degradednucleic acid since thePCRassayswere performedon
stored frozen stool, while culture was performed fresh. There were 4
Luminex-negative/Campylobacter ELISA detections which we iden-
tified as non-C. jejuni/C. coli infections, specieswhichwe deliberately
did not target.
The assay detected an additional 14 to 39% of infections for
Aeromonas, Campylobacter, Salmonella, Shigella, or Vibrio in the
clinical specimens beyond what was ascertained by conventional
means.We think this is highly plausible based on the prevalence of
these infections in Pakistan, Tanzania, and Bangladesh. We also
observed several mixed pathogens in these diarrhea cases. Such
mixed infectionsmake elucidating themost important etiologies a
vexing problem (36). There are a few basic biological possibilities
TABLE 2 Performance on clinical specimens
Characteristica
Value
Aeromonas Campylobacter Salmonella Shigella Vibrio Yersinia
No. of positive samples 35 52 23 48 25 2
No. of negative samples 170 153 182 157 180 203
cMFI cutoff 0.49 1.49 1.97 0.83 0.46 1.27
% sensitivity (95% CI) 89 (74–96) 89 (77–95) 96 (79–99) 94 (83–98) 92 (75–98) 100 (34–100)
% specificity (95% CI) 94 (89–96) 93 (88–96) 95 (91–97) 94 (89–97) 97 (93–98) 100 (98–100)
% PPV 74 81 71 83 79 100
% NPV 97 95 99 98 99 100
a CI, confidence interval; PPV, positive predictive value; NPV, negative predictive value.
TABLE 3 Testing of Luminex PCR/conventional test-discrepant
samples, with qPCR targeting a second gene
qPCR targeting a
second gene
No. of samples
% correlation
between
secondary
qPCR and
Luminex
Luminex PCR
positive/
conventional
test negative
Luminex PCR
negative/
conventional
test positive
Aeromonas 16S
qPCR positive
10 0 93
Aeromonas 16S
qPCR negative
1 4 93
Campylobacter 16S
qPCR positive
11 4a 76
Campylobacter 16S
qPCR negative
0 2 76
Salmonella ompC
qPCR positive
9 0 100
Salmonella ompC
qPCR negative
0 1 100
Shigella virA qPCR
positive
7 0 83
Shigella virA qPCR
negative
2 3 83
Vibrio hlyA/tlh
qPCR positive
6 0 100
Vibrio hlyA/tlh
qPCR negative
0 2 100
a These four Campylobacter 16S products were sequenced, and three were C. upsaliensis
and one was C. hyointestinalis.
PCR-Luminex Assay for Enteric Bacteria
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to mixed infections: both could be contributing to diarrhea, one
could be the main pathogen, while another asymptomatic or a
colonizer, or both could be colonizers.We feel that quantitation is
an important first step toward understanding this phenomenon,
under the hypothesis that high burden pathogens are more likely
contributors of disease. This represents a strength of this molecu-
lar approach over conventional approaches that are only qualita-
tive. In this work, wewere able to calculate the genome copy num-
ber of each pathogen in a sample from the standard curves
generated with a known copy number of genomic DNA, followed
by normalization for the particular stool sample’s extraction/am-
plification efficiency as monitored by extrinsic control under the
same principle as that demonstrated in our previous study (29).
This normalization improved quantitation, and a simple ratio of
target cMFI to extrinsic control cMFI yielded a number predictive
of bacterial load. Our results showed that the mixed infections
usually had a predominant organism with up to 4 logs more bac-
teria than the other organism. Relevant to quantitation is the fact
that most of our targets were single-copy chromosomal genes
(aerolysin, cadF, toxR, lysP, and invA) (15, 22, 25, 48). The ipaH
target is likely to be less useful, because its copy numbers vary
between species (42, 47). Additionally, the quantitation of most
targets was generally unaffected by the presence of other patho-
gens.
In our hands, the assay yielded results within 8 h, with about $9
in reagent costs per sample, including extraction, amplification,
and detection. It is implementable in any research or clinical lab-
oratorywith Luminex platforms, or the primers and probes can be
adapted to other technologies, such as standard real-time PCR or
microarray.
There were limitations to this work. First, our assay detects
only a limited number of clinically significant pathogens and does
not detect the diarrheagenic E. coli, protozoa, or viral targets. As
mentioned, we have intended this assay to be used in concert with
other multiplexed methods should those targets be considered.
For theCampylobacter assay, if one is considering rare species such
as Campylobacter upsaliensis or Campylobacter hyointestinalis,
then one should use another method, such as the 16S assay, since
we noted four cases ofC. upsaliensis orC. hyointestinaliswhere the
cadF PCR-Luminex was negative. Additionally, when Campylo-
bacter is detected together with high burdens of Salmonella or
Vibrio, the quantitation for Campylobacter is less accurate. An-
other limitation is that the Luminex assay requires a post-PCR
step, which adds a potential contamination risk compared with
closed platforms. Finally, our study did not include any prospec-
tive testing or correlation of quantitative results with clinical
symptoms or outcomes. The latter will take significant work, and
we hope to examine this at the Tanzania, Bangladesh, and Paki-
stan field sites in the near future.
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